Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


14 marzo 2016

A novel method of oedema fluid drainage in obstructive lymphoedema

Vascular News

According to the World Health Organization, around 300 million people are affected by the pathological oedema of limbs. Lymphoedema is caused by partial or total obstruction of lymphatic collectors as a consequence of skin and deep soft tissue inflammation, trauma of soft tissues and bones, lymphadenectomy and radiation in cancer therapy.

14 marzo 2016

Saphenous pulsation on duplex ultrasound is a marker of severe chronic superficial venous insufficiency

Vascular News

Saphenous pulsation is the cyclical impulse of antegrade flow observed on colour duplex ultrasound after prolonged standing. It is a common observation in patients with saphenous reflux and is detected in the upper part of the great saphenous vein, remote from neighbouring arterial interference. Interest in pulsation has been renewed by its potential as a marker of severe chronic superficial venous insufficiency.

29 marzo 2016

Patterns of symptomatic restenosis: less reintervention and reduced plaque burden with drug-eluting stent

Vascular News

Studies have indicated that patterns of restenosis affect long-term outcomes following retreatment in the superficial femoral artery. Gary Ansel, OhioHealth/Riverside Methodist Hospital, Columbus, USA, presented results at the Leipzig Interventional Course (LINC; 26–29 January 2016, Leipzig, Germany) showing that, when in-stent restenosis occurs, it is more often focal with a drug-eluting stent (Zilver PTX, Cook Medical), whereas it is more diffuse with bare metal stents. The drug-eluting device, according to Ansel, yields less restenosis, less reintervention and reduced plaque burden.

15 marzo 2016

Tack optimised balloon angioplasty safe and effective at six months

Vascular News

The six-month results of the TOBA BTK (Tack optimised balloon angioplasty below the knee) study show that the Tack endovascular system (Intact Vascular) demonstrated high levels of primary patency, freedom from target lesion revascularisation and total freedom from amputation.

14 marzo 2016

Hybrid operative thrombectomy is non-inferior to percutaneous techniques for acute iliofemoral deep vein thrombosis treatment

Vascular News

Hybrid operative thrombectomy achieves complete thrombus resolution in one operating room trip which results in reduced length of stay, bleeding complications and transfusions when compared with percutaneous treatments that use thrombolytic therapy. This can be achieved without sacrificing successful clinical or duplex results, according to data presented at the American Venous Forum (AVF; 24–26 February, Orlando, USA).

02 julio 2013

What is deep vein thrombosis? What is DVT?

Medical News Today

Deep vein thrombosis (DVT) refers to the formation of a blood clot (thrombus) in a deep vein in the leg. Deep vein thrombosis tends to occur in leg veins, such as the popliteal or femoral veins, as well as deep veins within the pelvis.

10 agosto 2015

Patients at risk of clots may be missing out on life-saving treatment

Medical News Today

The formation of blood clots in the veins known as venous thromboembolism is the most common cause of preventable death in hospitals. A new study has now revealed that significant numbers of patients are not receiving recommended treatment to prevent these clots from forming - even after health care providers underwent educational programs.

04 agosto 2015

New drug-entrapped artificial blood vessels stay clot-free

Medical News Today

Surgery for cardiovascular problems often requires the implantation of vascular grafts and stents to prop open failing or narrowed blood vessels. However, while this solves the immediate problem of restoring blood flow, it introduces the risk of blood clots.

17 febrero 2016

Clot removal may save money and limit disability

Medical News Today

Adding mechanical clot removal to clot-busting drugs could lower stroke survivors medical bills, decrease government healthcare as well as non-healthcare related costs, and increase the likelihood of the patient returning to work and participating in society, according to research presented at the American Stroke Associations International Stroke Conference 2016.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.